Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 68,735,803
- Total 13F value
- $2,755,924,776
- Share change
- +831,157
- Put/Call ratio
- 103%
- SEC-reported price per share
- $40.10
- Number of holders
- 227
- Value change
- +$28,159,264
- Number of buys
- 118
- Number of sells
- 101
- Shares outstanding
- 98,459,627
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q1 2023
Institutions
227
Top holders
10
RARE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Ownership snapshot
Top reported holders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 6.5%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 6.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VANGUARD GROUP INC
6.5%
WELLINGTON MANAGEMENT GROUP LLP
5.3%
BlackRock Finance, Inc.
4.4%
PRICE T ROWE ASSOCIATES INC /MD/
4.2%
RTW INVESTMENTS, LP
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
6.5%
|
$295,318,075
6,374,230 shares
|
— | 31 Dec 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
5.3%
|
$241,040,350
5,202,684 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.4%
|
$200,925,935
4,336,843 shares
|
— | 31 Dec 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.2%
|
$189,785,000
4,096,388 shares
|
— | 31 Dec 2022 |
| RTW INVESTMENTS, LP |
13F
Company
|
4%
|
$183,787,172
3,966,915 shares
|
— | 31 Dec 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
3.1%
|
$143,368,185
3,094,500 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
227
Shares
68,735,803
Rows available
227
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
225
Q1 2023 holders
227
Holder diff
2
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend